BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33152323)

  • 1. Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer.
    Biancur DE; Kapner KS; Yamamoto K; Banh RS; Neggers JE; Sohn ASW; Wu W; Manguso RT; Brown A; Root DE; Aguirre AJ; Kimmelman AC
    Cell Metab; 2021 Jan; 33(1):199-210.e8. PubMed ID: 33152323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells.
    Zhu XG; Chudnovskiy A; Baudrier L; Prizer B; Liu Y; Ostendorf BN; Yamaguchi N; Arab A; Tavora B; Timson R; Heissel S; de Stanchina E; Molina H; Victora GD; Goodarzi H; Birsoy K
    Cell Metab; 2021 Jan; 33(1):211-221.e6. PubMed ID: 33152324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer.
    Su Y; Li J; Witkiewicz AK; Brennan D; Neill T; Talarico J; Radice GL
    Oncogene; 2012 Oct; 31(41):4484-9. PubMed ID: 22158044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment.
    Sun H; Zhang B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820920969. PubMed ID: 32372692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing metabolic dependencies in pancreatic cancers.
    Encarnación-Rosado J; Kimmelman AC
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):482-492. PubMed ID: 33742165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.
    Reyes-Castellanos G; Abdel Hadi N; Carrier A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
    Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling pancreatic cancer in mice for experimental therapeutics.
    Mallya K; Gautam SK; Aithal A; Batra SK; Jain M
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188554. PubMed ID: 33945847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.
    Manzo T; Prentice BM; Anderson KG; Raman A; Schalck A; Codreanu GS; Nava Lauson CB; Tiberti S; Raimondi A; Jones MA; Reyzer M; Bates BM; Spraggins JM; Patterson NH; McLean JA; Rai K; Tacchetti C; Tucci S; Wargo JA; Rodighiero S; Clise-Dwyer K; Sherrod SD; Kim M; Navin NE; Caprioli RM; Greenberg PD; Draetta G; Nezi L
    J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32491160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.
    Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L
    Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
    Ozturk H; Cingoz H; Tufan T; Yang J; Adair SJ; Tummala KS; Kuscu C; Kinali M; Comertpay G; Nagdas S; Goudreau BJ; Luleyap HU; Bingul Y; Ware TB; Hwang WL; Hsu KL; Kashatus DF; Ting DT; Chandel NS; Bardeesy N; Bauer TW; Adli M
    Dev Cell; 2022 Jun; 57(11):1331-1346.e9. PubMed ID: 35508175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and pancreatic ductal adenocarcinoma.
    Yamasaki A; Yanai K; Onishi H
    Cancer Lett; 2020 Aug; 484():9-15. PubMed ID: 32380129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.
    Lau AN; Li Z; Danai LV; Westermark AM; Darnell AM; Ferreira R; Gocheva V; Sivanand S; Lien EC; Sapp KM; Mayers JR; Biffi G; Chin CR; Davidson SM; Tuveson DA; Jacks T; Matheson NJ; Yilmaz O; Vander Heiden MG
    Elife; 2020 Jul; 9():. PubMed ID: 32648540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
    Topalovski M; Hagopian M; Wang M; Brekken RA
    J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis.
    Carrer A; Trefely S; Zhao S; Campbell SL; Norgard RJ; Schultz KC; Sidoli S; Parris JLD; Affronti HC; Sivanand S; Egolf S; Sela Y; Trizzino M; Gardini A; Garcia BA; Snyder NW; Stanger BZ; Wellen KE
    Cancer Discov; 2019 Mar; 9(3):416-435. PubMed ID: 30626590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.
    Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI
    JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
    Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
    Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
    Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
    Biochim Biophys Acta; 2016 Dec; 1866(2):177-188. PubMed ID: 27600832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.